Biolight Life Sciences Ltdの収益はセグメントまたは地域別にどのように分けられていますか?
Biolight Life Sciences Ltdは収益を上げていますか?
Biolight Life Sciences Ltdに負債はありますか?
Biolight Life Sciences Ltdの発行済株式数は何株ですか?
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
1株当たり利益(TTM)
--
配当利回り
--
時価総額
--
BLLSFとは何ですか?
BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.